Deep learning platform aims to speed up developments
Zurich - Deep learning is indispensable in the development of complex applications such as driverless cars. The Zurich-based start-up Mirage Technologies is developing a deep learning platform to support companies in devising these kinds of products.
Zurich takes second place in global Smart City Index
Lausanne/Singapore - Zurich has been voted into second place as part of the first edition of the global Smart City Index. The index assesses the efforts and successes of a city in terms of the introduction of smart technologies to improve the lives of the people who live there.
Akero Therapeutics partners with InSphero
Schlieren ZH – US biotech firm Akero Therapeutics is now using InSphero’s human liver disease platform to screen the effects of one of its lead product candidates.
Microsoft opens research laboratory in Zurich
Zurich – Global IT giant Microsoft has opened a new laboratory in Zurich, where it will collaborate with the Swiss Federal Institute of Technology Zurich in the areas of mixed reality and artificial intelligence.
Vontobel launches a structured product on the blockchain
Zurich – The private bank Vontobel has expanded its digital financial assets portfolio by becoming the first issuer worldwide to offer a classic structured product for trading and custody using blockchain technology.
Psychologists develop app for parents
Zurich – Psychologists at the University of Zurich have developed an app to help parents monitor their child’s development of motor, cognitive and linguistic skills. Anonymized data from the app is then poured into research.
Zurich drones join Céline Dion world tour
Zurich – The Canadian pop icon Céline Dion is being accompanied on her new world tour by drones from the Zurich startup Verity Studios. During the singer’s concerts, the drones perform a dazzling show above the stage.
Eisai pours Swiss expertise into cancer therapies
Tokio/Wädenswil ZH – The Japanese pharmaceutical company Eisai is partnering with Numab Therapeutics AG from the Greater Zurich Area. Using a platform developed by Numab, Eisai will develop new cancer therapies.
Creoptix raises fresh capital
Wädenswil ZH – Creoptix has raised 8 million Swiss francs in a financing round. The start-up from the Greater Zurich Area develops analytical laboratory devices used in Life Sciences research and the pharmaceutical industry.
Meet with an expansion expert
Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center? Give us a call or drop us a line.